Details for New Drug Application (NDA): 021371
✉ Email this page to a colleague
The generic ingredient in ESTRASORB is estradiol hemihydrate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol hemihydrate profile page.
Summary for 021371
Tradename: | ESTRASORB |
Applicant: | Exeltis Usa Inc |
Ingredient: | estradiol hemihydrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | EMULSION;TOPICAL | Strength | 0.25% | ||||
Approval Date: | Oct 9, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021371
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Exeltis Usa Inc | ESTRASORB | estradiol hemihydrate | EMULSION;TOPICAL | 021371-001 | Oct 9, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription